Relmada Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RLMD and other ETFs, options, and stocks.

About RLMD

Relmada Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in addressing diseases of the central nervous system. It develops esmethadone, an N-methyl-D-aspartate receptor antagonist for the treatment of CNS diseases, and oral agent for depression and other potential indications. 

CEO
Sergio Traversa
CEOSergio Traversa
Employees
17
Employees17
Headquarters
Coral Gables, Florida
HeadquartersCoral Gables, Florida
Founded
2012
Founded2012
Employees
17
Employees17

RLMD Key Statistics

Market cap
21.41M
Market cap21.41M
Price-Earnings ratio
-0.24
Price-Earnings ratio-0.24
Dividend yield
—
Dividend yield—
Average volume
5.88M
Average volume5.88M
High today
$0.7373
High today$0.7373
Low today
$0.57
Low today$0.57
Open price
$0.735
Open price$0.735
Volume
1.87M
Volume1.87M
52 Week high
$4.47
52 Week high$4.47
52 Week low
$0.2404
52 Week low$0.2404
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.